Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records.
- DOI
- 10.1248/bpb.b26-00050
- Published
- 2026
- Container
- Biological & pharmaceutical bulletin
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1248/bpb.b26-00050,
title = {Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records.},
author = {Kei M and Sato S and Yamaga R and Karaki S and Uesawa Y and Ito T},
year = {2026},
journal = {Biological \& pharmaceutical bulletin},
doi = {10.1248/bpb.b26-00050},
url = {https://doi.org/10.1248/bpb.b26-00050}
}RIS
TY - JOUR TI - Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records. AU - Kei M AU - Sato S AU - Yamaga R AU - Karaki S AU - Uesawa Y AU - Ito T PY - 2026 JO - Biological & pharmaceutical bulletin DO - 10.1248/bpb.b26-00050 UR - https://doi.org/10.1248/bpb.b26-00050 ER -
APA
M, K., S, S., R, Y., S, K., Y, U., & T, I. (2026). Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records.. Biological & pharmaceutical bulletin. https://doi.org/10.1248/bpb.b26-00050
Source records
- pubmed · retrieved 2026-09-26T00:08:45.760Z